药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Levosimendan
Mefruside
Mefruside may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Meticrane
Meticrane may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Cicletanine
Cicletanine may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Spiradoline
Spiradoline may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Rolofylline
Rolofylline may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Canrenone
Canrenone may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Ertugliflozin
Ertugliflozin may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Isosorbide
Isosorbide may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Efonidipine
Efonidipine may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Canrenoic acid
Canrenoic acid may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Azosemide
Azosemide may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Tolvaptan
Tolvaptan may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Ularitide
Ularitide may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Tienilic acid
Tienilic acid may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Piretanide
Piretanide may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Drospirenone
Drospirenone may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Quinethazone
Quinethazone may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Diazoxide
Diazoxide may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Trichlormethiazide
Trichlormethiazide may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Levosimendan
Mersalyl
Metamfetamine may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.